Camp4 Therapeutics (CAMP) Amortization of Deferred Charges (2024 - 2026)
Camp4 Therapeutics (CAMP) reported Amortization of Deferred Charges of $34000.0 for Q1 2026, down 92.84% on a YoY basis from $475000.0 in Q1 2025, and down 92.92% sequentially from $480000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Amortization of Deferred Charges (2024 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 3 years of Amortization of Deferred Charges data on file, last reported at $34000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges fell 92.84% year-over-year to $34000.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 18.62% YoY), and the FY2025 full-year result was $1.9 million, up 9.95% from the prior year.
- Amortization of Deferred Charges fell to $34000.0 in Q1 2026, from $480000.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $489000.0 in Q3 2025 to a low of $34000.0 in Q1 2026.
- A 3-year average of $411777.8 and a median of $464000.0 in 2024 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges gained 17.87% in 2025 and slumped 92.84% in 2026, its largest moves.
- Tracing CAMP's Amortization of Deferred Charges over 3 years: stood at $464000.0 in 2024, then gained by 3.45% to $480000.0 in 2025, then tumbled by 92.92% to $34000.0 in 2026.
- Business Quant data shows CAMP's Amortization of Deferred Charges at $34000.0 in Q1 2026, $480000.0 in Q4 2025, and $489000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 480,000.00 |
| Dec 31, 2025 | 480,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Sep 30, 2025 | 489,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Jun 30, 2025 | 479,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Mar 31, 2025 | 475,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Dec 31, 2024 | 464,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Sep 30, 2024 | 450,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Jun 30, 2024 | 432,000.00 |
| Mar 31, 2024 | 403,000.00 |
| Mar 31, 2024 | 403,000.00 |